PRKAG2-AS1
gene geneOn this page
Summary
PRKAG2-AS1 (PRKAG2 antisense RNA 1, HGNC:40468) is a long non-coding RNA gene on chromosome 7q36.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:40468 |
| Approved symbol | PRKAG2-AS1 |
| Name | PRKAG2 antisense RNA 1 |
| Location | 7q36.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000239911 |
| Ensembl biotype | lncRNA |
| Entrez | 100505483 |
| RNAcentral | URS000075E0AB — lncRNA, 808 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 8 lncRNA
ENST00000464464, ENST00000467458, ENST00000687407, ENST00000689578, ENST00000690829, ENST00000702909, ENST00000765304, ENST00000793803
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000464464 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001813861 | 151878562 | 151878814 |
| ENSE00001824785 | 151877042 | 151877140 |
| ENSE00001876759 | 151877837 | 151877866 |
Expression profiles
Bgee: expression breadth ubiquitous, 217 present calls, max score 93.26.
FANTOM5 (CAGE): breadth broad, TPM avg 4.4389 / max 96.7332, expressed in 890 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 82112 | 3.0923 | 822 |
| 82113 | 0.4315 | 228 |
| 82114 | 0.3576 | 149 |
| 82110 | 0.3087 | 185 |
| 82111 | 0.2487 | 141 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| Brodmann (1909) area 23 | UBERON:0013554 | 93.26 | gold quality |
| middle temporal gyrus | UBERON:0002771 | 92.57 | gold quality |
| endothelial cell | CL:0000115 | 92.07 | gold quality |
| primary visual cortex | UBERON:0002436 | 90.31 | gold quality |
| prefrontal cortex | UBERON:0000451 | 89.03 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.76 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 88.74 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 88.40 | gold quality |
| occipital lobe | UBERON:0002021 | 88.11 | gold quality |
| lateral nuclear group of thalamus | UBERON:0002736 | 87.72 | gold quality |
| neocortex | UBERON:0001950 | 87.48 | gold quality |
| frontal cortex | UBERON:0001870 | 87.40 | gold quality |
| cerebral cortex | UBERON:0000956 | 86.65 | gold quality |
| right frontal lobe | UBERON:0002810 | 86.29 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 85.94 | gold quality |
| amygdala | UBERON:0001876 | 84.92 | gold quality |
| Ammon’s horn | UBERON:0001954 | 84.33 | gold quality |
| temporal lobe | UBERON:0001871 | 84.24 | gold quality |
| right lobe of liver | UBERON:0001114 | 84.18 | gold quality |
| postcentral gyrus | UBERON:0002581 | 83.81 | gold quality |
| parietal lobe | UBERON:0001872 | 83.58 | gold quality |
| monocyte | CL:0000576 | 83.42 | gold quality |
| leukocyte | CL:0000738 | 82.91 | gold quality |
| entorhinal cortex | UBERON:0002728 | 82.88 | gold quality |
| pons | UBERON:0000988 | 82.46 | gold quality |
| forebrain | UBERON:0001890 | 81.84 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 81.74 | gold quality |
| hypothalamus | UBERON:0001898 | 81.28 | gold quality |
| granulocyte | CL:0000094 | 81.15 | gold quality |
| adipose tissue | UBERON:0001013 | 80.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.95 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors. (PMID:32704143)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.